Cormorant Asset Management, LP Stoke Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

$1.74 Billion
Q1 2024

A detailed history of Cormorant Asset Management, LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 427,163 shares of STOK stock, worth $5.77 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

427,163

Previous 1,087,807 60.73%

Holding current value

$5.77 Million

Previous $5.72 Million 0.79%

% of portfolio

0.33%

Previous 0.34%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.12 - $14.17 $2.72 Million - $9.36 Million	-660,644 Reduced 60.73%	427,163 $5.77 Million
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $1.63 Million - $2.47 Million	-94,555 Reduced 8.0%	1,087,807 $22.9 Million
Q4 2021 Feb 14, 2022	SELL	$18.11 - $30.72 $1.74 Million - $2.95 Million	-95,914 Reduced 7.5%	1,182,362 $28.4 Million
Q2 2021 Aug 16, 2021	SELL	$30.53 - $41.09 $4.87 Million - $6.56 Million	-159,531 Reduced 11.1%	1,278,276 $43 Million
Q4 2020 Feb 16, 2021	SELL	$33.62 - $61.93 $3.36 Million - $6.19 Million	-100,000 Reduced 6.5%	1,437,807 $89 Million

Q3 2020 Nov 16, 2020	SELL	$22.23 - $37.48 $3.63 Million - $6.13 Million	-163,485 Reduced 9.61%	1,537,807 $51.5 Million
Q2 2020 Aug 14, 2020	SELL	$20.26 - $29.73 $171,662 - $251,902	-8,473 Reduced 0.5%	1,701,292 $40.5 Million
Q1 2020 May 15, 2020	SELL	$16.8 - $34.15 $1.33 Million - $2.69 Million	-78,878 Reduced 4.41%	1,709,765 $39.2 Million
Q4 2019 Feb 14, 2020	BUY	$20.01 - $30.79 $4,982 - $7,666	249 Added 0.01%	1,788,643 $50.7 Million
Q3 2019 Nov 14, 2019	SELL	$20.53 - $37.72 $1.67 Million - $3.07 Million	-81,286 Reduced 4.35%	1,788,394 $38.4 Million
Q2 2019 Aug 14, 2019	BUY	$25.53 - $29.17 $47.7 Million - $54.5 Million	1,869,680 New	1,869,680 $54.5 Million

Others Institutions Holding STOK

# of Institutions

111

Shares Held

50M

Call Options Held

63K

Put Options Held

111K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $533M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Stoke Therapeutics, Inc. Transaction History